Pharmacogenetic impact of SLC22A1 gene variant rs628031 (G/A) in newly diagnosed Indian type 2 diabetes patients undergoing metformin monotherapy

二甲双胍 药物遗传学 2型糖尿病 医学 基因型 内科学 等位基因 药理学 糖尿病 等位基因频率 内分泌学 基因 遗传学 生物 胰岛素
作者
Shalini Thakur Singh,Ashwin Kumar Shukla,Kauser Usman,Monisha Banerjee
出处
期刊:Pharmacogenetics and Genomics [Lippincott Williams & Wilkins]
卷期号:33 (3): 51-58 被引量:10
标识
DOI:10.1097/fpc.0000000000000493
摘要

OBJECTIVES: Type 2 diabetes (T2D) imposes an enormous burden all over the world in both developed and developing countries. Inter-individual differences are attributed to polymorphisms in candidate genes resulting in altered absorption, transportation, distribution, and metabolism of oral antidiabetic drugs (OADs). Hence, the present study was undertaken to evaluate the pharmacogenetic impact of SLC22A1 gene variant rs628031 (G/A) on metformin monotherapy in newly diagnosed untreated T2D patients. METHODS: Newly diagnosed T2D patients ( n = 500) were enrolled according to inclusion/exclusion criteria. Initially, enrolled subjects were prescribed metformin monotherapy and followed up for at least 12 weeks. Response to metformin was evaluated in 478 patients who revisited for follow-up by measuring HbA1c. RESULT: Out of 478 patients, 373 were responders to metformin monotherapy while 105 were non-responders. The pharmacogenetic impact was evaluated by genotype, haplotype, and pharmacogenetic analyses. 'GG' genotype and 'G' allele of SLC22A1 rs628031 G/A were observed in 48.8% and 67.7% of Met responders, respectively, while 20.9% and 49.1 % were in non-responders. Therefore, there was a 2.18-fold increase in the success rate of Met therapeutics. CONCLUSION: Individuals carrying the 'GG' genotype or 'G' allele for SLC22A1 gene variant rs628031 G/A are better responders for Metformin monotherapy.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
kklove发布了新的文献求助10
刚刚
1秒前
Jasper的应助被科研通管家采纳,获得10
1秒前
酷波er的应助被科研通管家采纳,获得10
1秒前
贪玩的新筠完成签到,获得积分10
1秒前
情怀的应助被科研通管家采纳,获得10
1秒前
aa的应助被科研通管家采纳,获得10
2秒前
Owen的应助被科研通管家采纳,获得10
2秒前
嘻嘻哈哈的应助被科研通管家采纳,获得10
2秒前
2秒前
2秒前
我是谁的应助被科研通管家采纳,获得20
2秒前
2秒前
大模型的应助被科研通管家采纳,获得10
2秒前
2秒前
Ava的应助被科研通管家采纳,获得10
2秒前
慕青的应助被科研通管家采纳,获得30
2秒前
3秒前
汉堡包的应助被科研通管家采纳,获得10
3秒前
3秒前
4秒前
呼初南发布了新的文献求助10
4秒前
Owen的应助被木子采纳,获得10
5秒前
熊林的应助被拉长的母鸡采纳,获得10
5秒前
5秒前
5秒前
是奶柚啊发布了新的文献求助10
6秒前
6秒前
1035646426完成签到,获得积分10
6秒前
6秒前
7秒前
7秒前
7秒前
TIANCHAICHAI完成签到,获得积分10
8秒前
Jasper的应助被lock821采纳,获得10
9秒前
刘66发布了新的文献求助10
9秒前
9秒前
anna1992发布了新的文献求助10
10秒前
放逐发布了新的文献求助10
10秒前
ccq的应助被生动的访琴采纳,获得10
10秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
What Else Can I Tell You?: A Pragmatic Study of English Rhetorical Questions as Discursive and Argumentative Acts 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8163614
求助须知:如何正确求助?哪些是违规求助? 9557702
关于积分的说明 21741573
捐赠科研通 7754282
什么是DOI,文献DOI怎么找? 3428275
关于科研通互助平台的介绍 2552989
邀请新用户注册赠送积分活动 2472923